We use some essential cookies to make this website work. These cookies are used to improve your website experience. To find out more about the cookies we use, see our Privacy Policy.
We’d also like to use analytics cookies so we can understand how you use the service and make improvements.
Use these toggles to accept or reject individual cookies. To find out more about the cookies we use, see our Privacy Policy.
Partnerships
Our partners leverage Concr advanced predictive modelling across every stage of therapeutic development to create shared value for the benefit of cancer patients.
Concr partnerships are typically shaped around a specific question. We collaborate with:
Meaningful and actionable biomarker predictions using 300x less pre-clinical and 7x less clinical data
Identify responders at the earliest stage of clinical drug development, mitigating risk of failure
Single analytical project can generate a wealth of clinically-actionable predictions, including new assets
10+ years of astrophysics research used to model tumour complexity and predict causes of its evolution
If you’d like more information or have an enquiry, please contact us.
